Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
2011
The Evolution of Beta-Blockers
publication
Evidence: moderate
Author Information
Author(s): Jillian G. Baker, Stephen J. Hill, Roger J. Summers
Hypothesis
How have beta-blockers evolved from their original use to potential new applications?
Conclusion
Beta-blockers have expanded their therapeutic uses beyond cardiovascular diseases to include conditions like anxiety, glaucoma, and potentially cancer and osteoporosis.
Supporting Evidence
- Beta-blockers were originally developed to treat heart conditions but are now used for various other medical issues.
- Recent studies suggest beta-blockers may help in treating osteoporosis and cancer.
- Beta-blockers can reduce anxiety symptoms by blocking the effects of adrenaline.
Takeaway
Beta-blockers are medicines that help with heart problems, but they can also help with other issues like anxiety and even some cancers.
Methodology
This review examines the historical development and current applications of beta-blockers in various medical conditions.
Limitations
The review does not provide new experimental data but summarizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website